EurekaMag.com logo
+ Translate

The prevalence of alpha 1 anti trypsin hetero zygotes pi mz in patients with obstructive pulmonary disease


, : The prevalence of alpha 1 anti trypsin hetero zygotes pi mz in patients with obstructive pulmonary disease. American Review of Respiratory Disease 114(6): 1077-1084

An increased incidence of an intermediate deficiency of serum .alpha.1-antitrypsin resulting from Pi phenotype MZ was reported in patients with chronic obstructive pulmonary disease (COPD). Prevalence of Pi MZ was determined in patients with COPD among 502 subjects referred to a pulmonary function testing laboratory in a region with low concentrations of air pollutants. Control prevalences were obtained from 930 randomly selected subjects in the same community as well as from patients without COPD. Depending on criteria used to define COPD, 155-306 subjects had COPD. Pi MZ prevalence in subjects with COPD varied from 1.5-4 times the prevalence in the community control group and in the patients without COPD. This difference approached significance or was significant. Because Pi MZ was present in only 3.5-4.5% of the patients with COPD, Pi MZ is not a major factor in the etiology of COPD in this community. The higher incidence of Pi MZ in patients with COPD may be explained by a small sample size, bias in selection of study or control population groups, or the development of COPD from interaction between Pi MZ and air pollutants or other factors not present in this community.

(PDF 0-2 workdays service)

Accession: 006740203

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Buist A.S.; Sexon G.J.; Azzam A M.H.; Adams B.E., 1979: Pulmonary function in hetero zygotes for alpha 1 anti trypsin deficiency a case control study. The initial cross-sectional data from a prospective study of lung aging in heterozygotes for .alpha.1-antitrypsin deficiency is presented. Using a case-control design, cases included 37 heterozygotes for .alpha.1-antitrypsin deficiency, protease i...

Tattersall S.F.; Hunter D.M.; Blundell G.; Pride N.B., 1977: Changes suggesting emphysema in hetero zygotes for alpha anti trypsin deficiency. Clinical Science & Molecular Medicine 52(2): 27P

Levison H., 1974: Lung function in alpha 1 anti trypsin hetero zygotes pi type mz. American Review Of Respiratory Disease: 708-715

Galdston, M.; Melnick, E.L.; Goldring, R.M.; Levytska, V.; Curasi, C.A.; Davis, A.L., 1977: Interactions of neutrophil elastase serum trypsin inhibitory activity and smoking history as risk factors for chronic obstructive pulmonary disease in patients with mm mz and zz phenotypes for alpha 1 anti trypsin. Patients with chronic obstructive pulmonary disease of the MM, MZ, and ZZ (Pi) phenotypes for .alpha.1-antitrypsin differed from healthy control subjects of these same Pi types by having greater mean neutrophilic polymorphonuclear leukocytes, lyso...

Mittman C.; Lieberman J.; Miranda A., 1969: Effect of smoking on lung function in alpha 1 anti trypsin hetero zygotes. Clinical Research 17(3): 553

Hepper N.G.; Black L.F.; Gleich G.J.; Kueppers F., 1969: The prevalence of alpha 1 anti trypsin a 1 at deficiency in selected groups of patients with chronic obstructive lung disease. Mayo Clinic Proceedings 44(10): 697-710

Lieberman J., 1969: Frequency of heterozygous and homozygous alpha anti trypsin deficiencies in patients with pulmonary emphysema abstract homo zygote hetero zygote enz trypsin inhibitory capacity serum assay inst spectrophotometry inherited major cause of disease. Clinical Medicine 17(1): 165

Black L.F.; Hyatt R.E., 1971: Mechanism of expiratory air flow limitation in patients with chronic obstructive pulmonary disease associated with alpha 1 anti trypsin deficiency. Am Rev Respir Dis 103(6): 891

Kanner R.E.; Klauber M.R.; Watanabe S.; Renzetti A.D.Jr; Bigler A., 1973: Pathologic patterns of chronic obstructive pulmonary disease in patients with normal and deficient levels of alpha anti trypsin. American Journal of Medicine 54(6): 706-712

Hammarsten J.F., 1980: Alpha 1 anti trypsin hetero zygotes pi type mz a longitudinal study of the risk of development of chronic air flow limitation. Chest: 261-264